Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcineurin Inhibitor Minimisation in Renal Transplant Recipients with Stable Allograft Function
2007-002914-20Phase 4Terminated
- Sponsor
- University Hospitals Birmingham
- Start
- Jul 2007
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of cyclosporine in kidney transplant (2 arms), sponsored by University Hospitals Birmingham. Primary endpoint: Histological graft damage progression. Started Jul 2007; status: terminated.
02
Drugs
cyclosporine
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2007-002914-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002914-20.